Pacific Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Pacific Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,609	Closed	-$1.88M	–	62
2024 Q4	$1.88M	Buy	3,609 +1,251	+53%	+$688K	1.1%	25
2024 Q3	$1.46M	Hold	2,358	–	–	0.85%	34
2024 Q2	$1.3M	Hold	2,358	–	–	0.86%	36
2024 Q1	$1.37M	Buy	2,358 +323	+16%	+$181K	0.9%	35
2023 Q4	$1.08M	Buy	2,035 +36	+2%	+$17.4K	0.81%	34
2023 Q3	$1.01M	Buy	+1,999	New	+$1.07M	0.61%	37

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pacific Capital Partners's TMO Position: Q1 2025 in Review

Pacific Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 3,609 shares — an estimated $1.88M sold.

Pacific Capital Partners first reported a position in TMO in Q3 2023 and held it in 6 quarters. The position peaked at $1.88M in Q4 2024. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Pacific Capital Partners reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
Pacific Capital Partners sold 3,609 Thermo Fisher Scientific shares in Q1 2025, an estimated $1.88M.
Pacific Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2023 and held it in 6 quarters.
Pacific Capital Partners's Thermo Fisher Scientific position peaked at $1.88M in Q4 2024.
2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Pacific Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.